Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/04/065129
CTRI/2024/04/065129
Not yet recruiting
未知

A COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 5% IMIQUIMOD CREAM VERSUS 10% KOH SOLUTION FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM IN THE PEDIATRIC AGE GROUP. - Koh,imiquimod, molluscum contagiosum

Bangalore Medical College and Research Institue0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Sponsor
Bangalore Medical College and Research Institue
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Bangalore Medical College and Research Institue

Eligibility Criteria

Inclusion Criteria

  • •1\.patient of either gender 0\-18yrs
  • •2\.Patients willing to give informed consent.
  • •3\.Patients willing for follow up.
  • •4\.All clinically diagnosed cases of Molluscum contagiosum, who have not taken any treatment in the past 2 weeks.

Exclusion Criteria

  • •Patients not willing to give informed consent.
  • •Patients more than 18years of age.
  • •Patients with secondary infection and hypersensitivity to imiquimod.
  • •Patients already on molluscum contagiosum treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
A diabetic study to find the safety and efficacy of newer drug Imeglimin.Health Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2023/06/053822Dr Shaki Sam
Completed
Phase 4
A Comparitive Study to Evaluate the Efficacy and Safety of Chlorthalidone with Losartan versus Amlodipine with Losartan in Patients With Primary HypertensioHealth Condition 1: I10- Essential (primary) hypertension
CTRI/2022/03/041375BMCRI80
Not yet recruiting
Phase 4
To determine the efficacy and safety of injection Labetalol Versus tablet Nifedipine in patients of severe pre-eclampsiaHealth Condition 1: O141- Severe pre-eclampsia
CTRI/2024/07/071651DrRida Rizvi
Not yet recruiting
Phase 4
TO EVALUATE THE EFFICACY AND SAFETY OF TENELIGLIPTIN VERSUS VILDAGLIPTIN AS AN ADD-ON TO METFORMIN IN DIABETES
CTRI/2018/06/014353Praveen A
Not yet recruiting
Phase 4
Efficacy of oral tranexamic acid and topical triple combination cream in treatment of melasmaHealth Condition 1: L814- Other melanin hyperpigmentation
CTRI/2024/04/065382MOHAN H